53 Results
Sort By:
Published on February 3, 2020
Precision health company Human Longevity announced it has published data in the journal Proceedings of the National Academy of Sciences(PNAS) demonstrating the ability of integrating whole-genome sequencing, imaging, and metabolomics to help identify adults at risk of specific health conditions. “The goal of precision medicine is to provide a path…
Published on July 8, 2019
While predictors of chronological and biological age came about several years ago, those that have recently been developed using deep learning methodologies are exponentially rising in popularity among researchers studying the mechanisms of aging. Advances in artificial intelligence, combined with the availability of large datasets, have led to a boom…
Published on March 19, 2018
Genomics Intelligence company Human Longevity, Inc. (HLI) announced Scott Sorensen as it chief technology officer, reporting to J. Craig Venter, Ph.D., co-founder, chairman and CEO. Sorensen joins HLI from consumer genomics company Ancestry where he held a variety of positions during his 16-year career. At Ancestry Sorensen helped develop the…
Published on September 13, 2017
A controversial study published last week in the Proceedings of the National Academy of Sciences (PNAS) by researchers from Human Longevity Inc. (HLI), the San Diego company cofounded by J. Criag Venter, which said they could scour an individual’s genome sequence and predict a handful of physical traits—including facial structure—has…
Published on June 15, 2017
Human Longevity Inc. (HLI) said today it has joined with Merck KGaA to identify treatment response biomarker signatures in patients with advanced melanoma, through a joint pilot project whose value was not disclosed. HLI and Merck KGaA will focus on identifying biomarkers in patients with locally advanced or metastatic NRAS…
Published on May 12, 2017
Offering Includes Whole Genome Sequencing and Full Body MRI to Give Insight into Cancer, Cardiovascular, Metabolic and Neurological Disease Risk Human Longevity, which focuses on a genomics-based approach to unlocking insights into human health launched Health Nucleus X (HNX) a pilot program designed to provide individuals and their physicians actionable…
Published on March 16, 2017
Genomic health intelligence company Human Longevity Inc. (HLI) recently announced an agreement with Massachusetts Mutual Life Insurance (MassMutual) to offer at a reduced price HLIQ Whole Genome, HLI’s whole genome sequencing product to eligible MassMutual customers, employees, and financial partners. “MassMutual has long believed that both financial and physical health are…
Published on November 30, 2015
Human Longevity Inc. (HLI) said today it has acquired Cypher Genomics for an undisclosed price, in a deal that adds human genomic interpretation software solutions to the buyer’s offerings. Based in San Diego, Cypher Genomics is a genome informatics company that has developed and markets Mantis™, software designed to enable customers to…
Published on September 22, 2015
Human Longevity Inc. (HLI) will partner with Discovery to offer whole exome, whole genome, and cancer genome sequencing to the insurer's clients in South Africa and the U.K. HLI will offer a full exome sequencing and analysis for Discovery's clients priced at $250. HLI will provide the information to Discovery,…
Published on May 14, 2015
Human Longevity (HLI) and the Cleveland Clinic agreed to collaborate to sequence and analyze blood samples from Cleveland Clinic's GeneBank study of de-identified patients. The two organizations will apply whole genome, cancer, and microbiome sequencing focusing on a subset of samples with the goal of discovering novel disease genes and…
Published on January 3, 2025
A team of researchers at Stanford Medicine has uncovered a molecular signature found in blood platelets shortly after vaccination could predict how long a person’s immune response will last. The finding, published in Nature Immunology, provides a new understanding of the factors related to vaccine durability that could eventually be…
Published on December 2, 2024
Researchers at the University of Texas and the University of California, Los Angeles (UCLA) say they have created a liquid ink that can be directly printed onto a patient’s scalp to measure brain activity, offering an alternative to traditional electroencephalography (EEG). The new technology, detailed in the journal Cell Biomaterials,…
Published on November 22, 2024
A team from genetic testing firm MapmyGenome has found nine variants linked to longevity in the Indian population. At least one variant, the G allele of rs2802292 from the FOXO3A gene, has been found in populations in other countries. The study appeared in NPJ Aging and was led by Sandhya Kiran…
Published on October 9, 2024
A new study published in Rheumatology by researchers from the Sapienza University of Rome, Italy, and the Oxford University Press suggests that caffeine could benefit heart health by supporting the body’s blood vessels, especially in patients with systemic lupus erythematosus (SLE). This study is among the first to investigate the…
Published on September 17, 2024
Certain rare variants have around five times larger effects on menopause timing than do previously identified common variants. Those rare variants included ETAA1, ZNF518A, PNPLA8, PALB2, and SAMHD1. A British research team mined UK BioBank data for this study, which appeared in Nature. Further, they found that damaging germline variants…